- Avotermin for the improvement of scar appearance: a new pharmaceutical in a new therapeutic area
[作者:Occleston, NL; Fairlamb, D; Hutchison, J; O'Kane, S; Ferguson, MWJ,期刊:Expert opinion on investigational drugs, 页码:1231-1239 , 文章类型: Editorial Material,,卷期:2009年18-8]
- Disfiguring scarring in the skin is an area of high medical need. Current treatments for scarring have variable or limited effectiveness and have typically not been evaluated in randomized, controlled, double-blind clini...
- Can we predict the effects of NF-kappa B inhibition in sepsis? Studies with parthenolide and ethyl pyruvate
[作者:Li, XM; Su, JW; Cui, XZ; Li, Y; Barochia, A; Eichacker, PQ,期刊:Expert opinion on investigational drugs, 页码:1047-1060 , 文章类型: Review,,卷期:2009年18-8]
- Background: Based partially on encouraging findings from preclinical models, interest has grown in therapeutic inhibition of NF-kappa B to limit inflammatory injury during sepsis. However, NF-kappa B also regulates prote...
- Glioblastoma multiforme: a review of where we have been and where we are going
[作者:Adamson, C; Kanu, OO; Mehta, AI; Di, CH; Lin, NJ; Mattox, AK; Bigner, DD,期刊:Expert opinion on investigational drugs, 页码:1061-1083 , 文章类型: Review,,卷期:2009年18-8]
- Malignant gliomas such as glioblastoma multiforme (GBM) present some of the greatest challenges in the management of cancer patients worldwide, despite notable recent achievements in oncology. Even with aggressive surgic...
- Investigational vasopressin receptor modulators in the pipeline
[作者:Favory, R; Salgado, DR; Vincent, JL,期刊:Expert opinion on investigational drugs, 页码:1119-1131 , 文章类型: Review,,卷期:2009年18-8]
- The vasopressin system is complex and interacts with the central nervous, cardiovascular, renal, and hematological systems. Vasopressin plays an important role in the control of blood osmolarity and vascular tone, but is...
|